United Therapeutics | UTHR - Zinsaufwendungen Für Schuld

Aktienkurs
567.16
Täglich Wechseln
-5.69 -0.99%
Monatlich
4.72%
Jährlich
94.65%
Q2 Prognose
555.02




Zinsaufwendungen Für Schuld Veränderung Datum
Amarin USD 3K 5K 2024-12
Ardelyx USD 5.76M 37K 2025-12
Baxter International USD 58M 14M 2025-09
Bayer EUR 675M 87M 2025-12
BioCryst Pharmaceuticals USD 14.14M 5.53M 2025-12
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Esperion Therapeutics USD 22.64M 585K 2025-12
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Halozyme Therapeutics USD 4.91M 615K 2025-12
Insmed USD 20.6M 217K 2025-12
Ionis Pharmaceuticals USD 18M 0 2025-12
J&J USD 43M 25M 2026-03
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Moderna USD 12.14B 12.13B 2025-09
Omeros USD 4.05M 5.16M 2024-09
Pfizer USD 711M 59M 2025-12
PTC Therapeutics USD 50.58M 2.59B 2025-12
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Sangamo BioSciences 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Teva Pharmaceutical Industries USD 220M 17M 2025-12
United Therapeutics USD 3.1M 100K 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12